NSE BSE
sun pharma adv.res.co.ltd stock

SUN PHARMA ADV.RES.CO.LTD Share Price

- - (%)
- NSE: SPARC

SUN PHARMA ADV.RES.CO.LTD Share Price Update

As of the latest trading session, SUN PHARMA ADV.RES.CO.LTD share price is currently at 235.9, which is down by -1.88 from its previous closing. Today, the stock has fluctuated between 235.00 and 241.55. Over the past year, SUN PHARMA ADV.RES.CO.LTD has achieved a return of 3.27 %. In the last month alone, the return has been 8.60 %. Read More...

SUN PHARMA ADV.RES.CO.LTD Performance

Day Range

Low235.00 High241.55
235.90

52 Week Range

Low 196.10 High 472.80
235.90

SUN PHARMA ADV.RES.CO.LTD Share Price

14788

532872

SPARC

img img img img
No Data Available

Open Price

239.50

Prev. Close

237.79

Volume (Shares)

474527.00

Total traded value

1119.40

Upper Circuit

261.56

Lower Circuit

214.01

Note: The current prices & values are delayed, Login to your account for live updates.

SUN PHARMA ADV.RES.CO.LTD Fundamentals


(Standalone)

Market Cap (Cr) 7655.50
PE Ratio (TTM) 0.00
Book Value / Share 3.84
Beta 0.87
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -106.69

SUN PHARMA ADV.RES.CO.LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 16.56
Operating Expense 127.64
Net Profit -106.69
Net Profit Margin (%) -644.26
Earnings Per Share (EPS) -3.29
EBITDA -103.12
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 13.86
Operating Expense 119.90
Net Profit -99.65
Net Profit Margin (%) -718.97
Earnings Per Share (EPS) -3.07
EBITDA -96.23
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 21.18
Operating Expense 116.09
Net Profit -86.42
Net Profit Margin (%) -408.02
Earnings Per Share (EPS) -2.66
EBITDA -82.97
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 23.95
Operating Expense 129.48
Net Profit -95.35
Net Profit Margin (%) -398.12
Earnings Per Share (EPS) -2.94
EBITDA -91.99
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 47.69
Operating Expense 140.41
Net Profit -81.99
Net Profit Margin (%) -171.92
Earnings Per Share (EPS) -2.55
EBITDA -78.84
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 75.55
Operating Expense 493.13
Net Profit -388.11
Net Profit Margin (%) -513.71
Earnings Per Share (EPS) -11.96
EBITDA -374.32
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 238.78
Operating Expense 472.24
Net Profit -222.58
Net Profit Margin (%) -93.21
Earnings Per Share (EPS) -7.82
EBITDA -203.18
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 137.25
Operating Expense 347.49
Net Profit -203.40
Net Profit Margin (%) -148.19
Earnings Per Share (EPS) -7.73
EBITDA -179.91
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 252.96
Operating Expense 409.51
Net Profit -151.14
Net Profit Margin (%) -59.74
Earnings Per Share (EPS) -5.77
EBITDA -129.57
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 76.82
Operating Expense 398.98
Net Profit -312.40
Net Profit Margin (%) -406.66
Earnings Per Share (EPS) -11.92
EBITDA -300.24
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 15.80
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.17
EBITDA Margin -85.09
Particulars MAR 2022 (Values in Cr)
Book Value / Share -7.47
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -131.07
Particulars MAR 2021 (Values in Cr)
Book Value / Share -6.42
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -51.22
Particulars MAR 2020 (Values in Cr)
Book Value / Share -0.71
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.25
EBITDA Margin -390.90
Particulars MAR 2019 (Values in Cr)
Book Value / Share 11.30
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.01
EBITDA Margin -75.35
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 111.57
Total Assets 830.12
Total Liabilities 830.12
Total Equity 512.77
Share Outstanding 324521588
Price to Book Ratio 11.36
Return on Assets (%) -26.81
Return on Capital (%) -43.4
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.22
Total Assets 280.08
Total Liabilities 280.08
Total Equity 31.22
Share Outstanding 271878966
Price to Book Ratio -39.74
Return on Assets (%) -72.61
Return on Capital (%) -191.47
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 9.31
Total Assets 229.68
Total Liabilities 229.68
Total Equity -168.25
Share Outstanding 262047506
Price to Book Ratio -22.07
Return on Assets (%) -65.80
Return on Capital (%) -242.62
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.45
Total Assets 272.56
Total Liabilities 272.56
Total Equity -18.63
Share Outstanding 262047506
Price to Book Ratio -135.92
Return on Assets (%) -114.61
Return on Capital (%) -654.39
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.67
Total Assets 398.47
Total Liabilities 398.47
Total Equity 296.23
Share Outstanding 262047506
Price to Book Ratio 16.99
Return on Assets (%) -36.49
Return on Capital (%) -48.91
Particulars MAR 2023 (Values in Cr)
Net Income -222.58
Cash from Operations -74.48
Cash from Investing -548.27
Cash from Financing 616.75
Net change in Cash -0.64
Free Cash Flow -59.09
Particulars MAR 2022 (Values in Cr)
Net Income -203.39
Cash from Operations -212.77
Cash from Investing -29.16
Cash from Financing 229.32
Net change in Cash -8.07
Free Cash Flow -180.09
Particulars MAR 2021 (Values in Cr)
Net Income -151.13
Cash from Operations -150.26
Cash from Investing 1.56
Cash from Financing 159.28
Net change in Cash 8.95
Free Cash Flow -144.26
Particulars MAR 2020 (Values in Cr)
Net Income -312.40
Cash from Operations -200.94
Cash from Investing 155.34
Cash from Financing 55.46
Net change in Cash 0.00
Free Cash Flow -146.90
Particulars MAR 2019 (Values in Cr)
Net Income -145.43
Cash from Operations -167.37
Cash from Investing -102.18
Cash from Financing 274.24
Net change in Cash 0.14
Free Cash Flow -154.42
Company Name Price P/E P/B Market Cap 52 Week Low/High
SUN PHARMA ADV.RES.CO.LTD 237.50 0.00 61.29 7707.39 196.45 / 474.00
BLISS GVS PHARMA LTD 116.40 12.72 1.26 1219.15 77.65 / 148.95
CIPLA LTD 1505.80 28.56 4.55 121596.06 1018.30 / 1581.70
FERMENTA BIOTECH LIMITED 203.65 0.00 2.07 599.36 136.00 / 219.05
GLAXOSMITHKLINE PHARMA LT 2559.65 66.04 24.39 43362.02 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
SUN PHARMA ADV.RES.CO.LTD 237.50 0.00 61.73 7707.39 196.45 / 474.00
AMRUTAJAN HEALTH LTD 761.05 48.91 7.62 2200.24 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6864.45 114.79 24.10 17161.13 3650.05 / 7550.00
BLISS GVS PHARMA LTD 116.40 16.01 1.23 1219.15 77.65 / 148.95
ABBOTT INDIA LIMITED 27823.05 49.22 15.98 59123.98 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 241.50
  • 26 Days 234.30
  • 10 Days 242.20
  • 50 Days 231.80
  • 12 Days 241.90
  • 100 Days 273.90
  • 20 Days 238.80
  • 200 Days 242.10
238.96
PIVOT
First Resistance 242.83
Second Resistance 247.86
Third Resistance 251.73
First Support 233.93
Second Support 230.06
Third Support 225.03
RSI 50.04
MACD 7.59
Commodity Channel Index (CCI) -24.62
ADX 39.95
Williams % R -81.16

Over 1 Month

down

8.60

Over 3 Months

down

-41.75

Over 6 Months

down

-38.33

Over 1 Year

down

3.27

Over 3 Years

down

-0.99

Over 5 Years

down

14.78

SUN PHARMA ADV.RES.CO.LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

SUN PHARMA ADV.RES.CO.LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
30.84
Promoter Holdings
65.67
FII
3.23
DII
0.25
Promoter Shares(Pledge Percentage)
2.78
Name Category Shares Shares%
Shanghvi Finance Private Limited Shareholding of Promoter and Promoter Group 1.37211787E8 42.28
Dilip Shantilal Shanghvi Shareholding of Promoter and Promoter Group 6.181066E7 19.05
Sun Pharmaceutical Industries Key Employees Benefit Trust Public Shareholding 1.0317377E7 3.18
Jhunjhunwala Rekha Rakesh Public Shareholding 6292134.0 1.94
Lakshdeep Investments & Finance (p) Ltd. Public Shareholding 5133835.0 1.58
Aditya Medisales Limited Shareholding of Promoter and Promoter Group 4888126.0 1.51
Raksha S.valia Shareholding of Promoter and Promoter Group 4145231.0 1.28
Vijay Mohanlal Parekh Public Shareholding 3661304.0 1.13
Paresh Mohanlal Parekh Public Shareholding 3646837.0 1.12
Enam Securities Private Limited Public Shareholding 3370786.0 1.04
Sudhir Valia Shareholding of Promoter and Promoter Group 1833951.0 0.57
Unimed Investments Limited Shareholding of Promoter and Promoter Group 1267963.0 0.39
Vibha Dilip Shanghvi Shareholding of Promoter and Promoter Group 1063236.0 0.33
Vidhi Dilip Shanghvi Shareholding of Promoter and Promoter Group 344081.0 0.11
Aalok Dilip Shanghvi Shareholding of Promoter and Promoter Group 350162.0 0.11
Shanghvi Family & Friends Benefit Trust (kumud S. Shanghvi And Dilip S. Shanghvi) Shareholding of Promoter and Promoter Group 154922.0 0.05
Kumud S. Shanghvi Shareholding of Promoter and Promoter Group 38795.0 0.01
Gujarat Sun Pharmaceutical Industries Pvt Ltd Shareholding of Promoter and Promoter Group 1751.0 0.0
Sanghvi Properties Private Limited Shareholding of Promoter and Promoter Group 1887.0 0.0
Flamboyawer Finance Private Limited Shareholding of Promoter and Promoter Group 2543.0 0.0

SUN PHARMA ADV.RES.CO.LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About SUN PHARMA ADV.RES.CO.LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SUN PHARMA ADV.RES.CO.LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Sun Pharma Advanced Research Company Ltd?

Answer Field

The share price of Sun Pharma Advanced Research Company Ltd for NSE is ₹ 235.9 and for BSE is ₹ 236.

What is the Market Cap of Sun Pharma Advanced Research Company Ltd?

Answer Field

The market cap of Sun Pharma Advanced Research Company Ltd for NSE is ₹ 7,655.50 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Sun Pharma Advanced Research Company Ltd?

Answer Field

The 52 Week High and Low of Sun Pharma Advanced Research Company Ltd for NSE is ₹ 472.80 and ₹ 196.10 and for BSE is ₹ 474.00 and ₹ 196.45.

How to Buy Sun Pharma Advanced Research Company Ltd share?

Answer Field

You can trade in Sun Pharma Advanced Research Company Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Sun Pharma Advanced Research Company Ltd?

Answer Field

The 1 year returns on the stock has been 3.27%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader